Core Insights - Xiaomi Group reported record-high financial results for Q2 2025, with revenue reaching 116 billion yuan, a year-on-year increase of 30.5%, marking the third consecutive quarter of exceeding 100 billion yuan [2] - Adjusted net profit for the quarter was 10.8 billion yuan, a significant year-on-year increase of 75.4%, continuing a trend of surpassing 10 billion yuan for two consecutive quarters [2] - Revenue from innovative businesses, including smart electric vehicles and AI, surpassed 20 billion yuan [2] Financial Performance - Xiaomi's automotive deliveries reached 81,302 units in Q2, with total deliveries exceeding 300,000 units as of July 10 [2] - The automotive business reported a reduced operating loss of 300 million yuan in Q2, with expectations of profitability in the second half of the year [2] - Revenue from smartphone and AIoT businesses was 94.7 billion yuan, a year-on-year increase of 14.8%, with smartphone revenue at 45.5 billion yuan [2][3] Market Position - Despite a challenging global smartphone market, Xiaomi achieved a market share of 16.8% in China, leading the domestic market with 11.5 million new device activations in Q2 [3] - Xiaomi's smartphone shipments have seen growth for eight consecutive quarters, ranking in the top five in 69 countries and regions [3] IoT and Consumer Products - Revenue from IoT and consumer products reached 38.7 billion yuan, with smart home appliances seeing a year-on-year revenue increase of 66.2% [2][3] - In Q2, Xiaomi's air conditioning product shipments exceeded 5.4 million units, marking a historical high with a growth rate of over 60% [3] - The company also reported significant growth in refrigerator and washing machine shipments, with increases of over 25% and 45%, respectively [3] High-End Market Strategy - Xiaomi's high-end smartphone sales accounted for 27.6% of total smartphone sales in mainland China, an increase of 5.5 percentage points year-on-year [4] - The company expanded its market share in the 4000-5000 yuan price segment to 24.7% and achieved a market share of 15.4% in the 5000-6000 yuan segment, a year-on-year increase of 6.5 percentage points [4] R&D Investment - R&D expenditure reached 7.8 billion yuan in Q2, a year-on-year increase of 41.2%, with an expected total investment of 30 billion yuan for the year [5] - Significant investments in foundational technologies are anticipated to drive breakthroughs in automotive, chip, and AI sectors [5]

Market Overview - The Hang Seng Index recently peaked at 25,700 points but has since declined, with a current support level around 25,000 points, indicating potential downward adjustment risks [1][2] - The distribution of bull and bear certificates shows 69% are bullish and 31% bearish, suggesting a prevailing bullish sentiment despite the recent market pullback [1][3] Investment Products - For investors considering bull certificates, it is advised to select products with a recovery price not too close to the current market price to mitigate risks [1] - Specific products mentioned include: - Bull certificate 65915 with a recovery price of 24,818 points and a leverage of 50-60 times [1] - Bear certificate 65929 with a recovery price of 25,688 points and a leverage of 40 times [2] - Call warrant 18057 with an exercise price of 25,627 points and a leverage of 10 times, expiring in December [1] - Put warrant 19402 with an exercise price of 24,477 points and a leverage of 8 times, expiring in January [1] Individual Stock Analysis - Xiaomi (01810) is experiencing volatility ahead of its earnings announcement, with a current price around 51-52 HKD after a recent drop to 50.1 HKD [5][6] - Investors are favoring call warrants for Xiaomi, such as warrant 17257 with an exercise price of 61 HKD and a leverage of 5 times, expiring in April [5] - Hong Kong Exchanges and Clearing (00388) is benefiting from high trading volumes and new IPOs, with a suggested call warrant 17568 at an exercise price of 530.5 HKD and a leverage of 7 times [8][9] Sector Focus - The semiconductor sector is currently in focus, with companies like SMIC (00981) and Hua Hong Semiconductor (01347) facing price adjustments [12][13] - Investment products for SMIC include call warrant 18978 with an exercise price of 62.88 HKD and a leverage of 3 times, and put warrant 13689 with an exercise price of 42.5 HKD, also with a leverage of 3 times [12] - For Hua Hong, call warrant 19312 with an exercise price of 55 HKD and a leverage of 2 times is available [12] Risk Management - Investors are advised to monitor support and resistance levels closely when selecting products, particularly for high-leverage options [18][19] - The current support level for Xiaomi is around 49.2 HKD, while the resistance level is at 57.5 HKD [6][9]

Core Viewpoint - Xiaomi Group reported a significant increase in revenue and net profit for Q2 2025, indicating strong growth despite challenges in the smartphone segment [3][4]. Financial Performance - Xiaomi Group's revenue for Q2 2025 reached 116 billion RMB, a year-on-year increase of 30.5% [3]. - The adjusted net profit for the same period was 10.8 billion RMB, reflecting a year-on-year growth of 75.4% [3]. - The gross profit for the smartphone segment was 5.22 billion RMB, with a gross margin of 11.5%, down from 12.1% in the previous year [3][4]. - IoT and lifestyle products generated a gross profit of 8.72 billion RMB, with a gross margin of 22.5%, up from 19.7% year-on-year [3]. - Internet services revenue was 6.86 billion RMB, with a gross margin of 75.4%, slightly down from 78.3% [3]. Segment Performance - Smartphone revenue decreased by 2.1% year-on-year to 45.5 billion RMB, attributed to a decline in average selling price (ASP) in overseas markets [4]. - IoT and lifestyle products saw a revenue increase of 44.7% year-on-year, reaching 38.7 billion RMB [4]. - Internet services revenue grew by 10.1% year-on-year to 9.1 billion RMB [4]. - The innovative business segment, including smart electric vehicles and AI, generated 21.3 billion RMB in revenue, with a loss of 300 million RMB [4]. Market Outlook - The smartphone market is expected to experience zero or minimal growth, leading Xiaomi to revise its sales target for the year to approximately 175 million units [5]. - The company aims to optimize product structure and improve ASP in response to market conditions [5]. - Xiaomi's R&D investment for the quarter was 7.8 billion RMB, a year-on-year increase of 41.2%, with an expected total investment of 30 billion RMB for the year [6].

Core Insights - Xiaomi Group reported record high revenue and net profit for Q2, achieving revenue of 116 billion yuan, a year-on-year increase of 30.5%, and an adjusted net profit of 10.8 billion yuan, up 75.4% [2] Smartphone Business - Despite a challenging global smartphone market, Xiaomi's smartphone business saw significant growth, with 11.5 million new device activations in Q2, capturing a 16.8% market share in China, ranking first [2] - Xiaomi aims to maintain its annual smartphone shipment target at approximately 175 million units, focusing on increasing average selling price (ASP) and market share in China by 1 percentage point each year [2][3] Automotive Sector - Xiaomi's smart electric vehicle and AI innovation segment generated over 20 billion yuan in revenue, entering a phase of rapid growth, with Q2 vehicle deliveries reaching 81,302 units, totaling over 300,000 cumulative deliveries by July 10 [3] - The company is committed to avoiding price wars in the competitive electric vehicle market, prioritizing order fulfillment and aiming for profitability in the second half of the year [3] Home Appliances - In the home appliance sector, Xiaomi achieved "volume and price increase" amidst fierce competition, leveraging its advantages in smart home technology and user-centric innovation to transform the traditional appliance market [4]

Major Events - CSPC Pharmaceutical Group (01093) received clinical trial approval for Dupilumab injection in China [1] - Rongchang Biopharmaceutical (09995) was granted breakthrough therapy designation for RC148 for non-small cell lung cancer by the National Medical Products Administration [1] - China Biologic Products (01177) included LM-302 "CLDN18.2 ADC" in the breakthrough therapy program [1] - Sunshine Oilsands (02012) plans to acquire 51% stake in Noble Technology Limited for HKD 50.91945 million [1] - Galenica Pharmaceutical-B (01672) plans to issue shares at a discount of approximately 9.9%, raising HKD 468 million [1] Financial Performance - Xiaomi Group-W (01810) reported record high revenue and profit for Q2, with attributable profit of HKD 11.904 billion, up 133.51% year-on-year [1] - Pop Mart (09992) announced a mid-term profit of HKD 4.574 billion, a year-on-year increase of 396.5% [1] - Fuyao Glass (03606) reported a half-year net profit of approximately HKD 4.805 billion, up 37.33% year-on-year [1] - China Resources Beer (00291) announced a mid-term profit of HKD 5.789 billion, an increase of 23.04% year-on-year [1] - Kunlun Energy (00135) reported a mid-term profit of HKD 3.161 billion, down 4.36% year-on-year, with a dividend of HKD 0.166 per share [1] - WuXi Biologics (02269) reported a mid-term profit of approximately HKD 2.339 billion, up 56% year-on-year [1] - Sunny Optical Technology (02382) announced a mid-term profit of HKD 1.646 billion, an increase of 52.56% year-on-year [1] - Yixin Group (02858) reported an adjusted net profit of HKD 648 million, up 28% year-on-year [1] - Kangchen Pharmaceutical (01681) reported a mid-term profit of HKD 498 million, up 24.6% year-on-year, maintaining market leadership with its flagship product [1] - Ping An Good Doctor (01833) reported a mid-term profit of HKD 134 million, a year-on-year increase of 136.84% [1] - China Communication Services (02342) reported a mid-term profit of HKD 61.781 million, returning to profitability [1] - XPeng Motors-W (09868) achieved record levels in core business and financial metrics for Q2, with a net loss of HKD 480 million, narrowing by 62.8% year-on-year [1] - Guochuang Tongqiao (02190) reported a mid-term profit of HKD 121 million, up 76% year-on-year [1] - Yanda Pharmaceutical (00512) reported record revenue of HKD 6.107 billion [1] - Jinli Permanent Magnet (06680) reported a mid-term profit of approximately HKD 305 million, up 154.81% year-on-year [1] - Zhaogang Group-W (06676) issued a profit warning, expecting a mid-term profit of approximately HKD 140 million to HKD 180 million, returning to profitability [1] - Longyuan Power (00916) reported a mid-term profit of HKD 3.519 billion, down 14.4% year-on-year [1] - Yancoal Australia (03668) reported a mid-term profit of AUD 16.3 million, down 61.19% year-on-year [1] - SF Holding (06936) reported total revenue of HKD 24.847 billion for July in logistics, supply chain, and international business, up 9.95% year-on-year [1] - Chow Sang Sang (00116) expects a mid-term profit from continuing operations of approximately HKD 900 million to HKD 920 million [1]

【#小米2027年进军欧洲汽车市场##小米计划手机年出货量突破2亿台#】小米集团 2025 年第二季度总收 入达 1160 亿元，同比增长 30.5%，创下历史新高；公司净利润为 119 亿元，同比增长 134.2%；经调整 净利润为 108 亿元，同比增长 75.4%。 小米在本季度交付新车 81302 辆，较去年同期增长 197.7%，进一步推动小米电动汽车业务收入同比增 长 233.9% 达到 213 亿元。 在今晚的媒体电话会议上，小米集团总裁卢伟冰表示：YU 7 系列延续了 SU7 的耀眼表现，"再次创造 了小米的爆款奇迹"，公司决定在 2027 年正式进入欧洲电动汽车市场。 卢伟冰表示，小米汽车业务二季度经营亏损收窄至 3 亿元，按照当前的速度，有望在下半年单月或单季 盈利；但过去三年多投入超 300 亿元，累计亏损仍巨大，全面盈利还有很长一段路要走。 对于手机业务，卢伟冰表示小米手机坚定瞄准"2 亿俱乐部"，即计划未来三到五年跻身全球年出货量 2 亿台行列。 在被问到家电反内卷问题时，卢伟冰表示，小米坚决不打价格战、不参与内卷。他还提到，2025 全年 小米集团整体收入预计增长 30% 以上，对 ...

Group 1 - Xiaomi Group-W (01810.HK) reported a record revenue of RMB 116 billion and a net profit of RMB 10.8 billion for Q2 2025, marking a year-on-year increase of 30.5% and 75.4% respectively [1] - The "Mobile × AIoT" segment generated RMB 94.7 billion in revenue, up 14.8% year-on-year, while the "Smart Electric Vehicles and AI Innovation" segment reached RMB 21.3 billion, both achieving historical highs [1] - The total smartphone shipments for Q2 2025 were 42.4 million units, reflecting a 0.6% year-on-year growth, maintaining a global market share of 14.7% and ranking among the top three for 20 consecutive quarters [2] Group 2 - Xiaomi's active user base reached a record high of 731.2 million globally by June 2025, representing an 8.2% year-on-year increase [2] - The number of connected IoT devices on Xiaomi's AIoT platform grew to 989.1 million, a 20.3% increase year-on-year [2] - Research and development expenditure for Q2 2025 was RMB 7.8 billion, up 41.2% year-on-year, with the number of R&D personnel reaching a historical high of 22,641 [2] Group 3 - Xiaomi's retail presence expanded significantly, with over 1,700 new Xiaomi Home stores opened in mainland China, bringing the total to over 17,000, while international retail stores reached approximately 200 [2]

Major Events - CSPC Pharmaceutical Group (01093) received clinical trial approval for Dupilumab injection in China [1] - Rongchang Bio (09995) was granted breakthrough therapy designation for RC148 for non-small cell lung cancer by the National Medical Products Administration [1] - China Biologic Products (01177) included LM-302 "CLDN18.2 ADC" in the breakthrough therapy program [1] - Sunshine Oilsands (02012) plans to acquire 51% of Noble Technology Limited for HKD 50.91945 million [1] - Galenica Pharmaceutical-B (01672) plans a placement at a discount of approximately 9.9%, raising HKD 468 million [1] Operating Performance - Xiaomi Group-W (01810) reported record high revenue and profit for Q2, with attributable profit of HKD 11.904 billion, a year-on-year increase of 133.51% [1] - Pop Mart (09992) announced a mid-term profit attributable to shareholders of HKD 4.574 billion, a year-on-year increase of 396.5% [1] - Fuyao Glass (03606) reported a half-year net profit of approximately HKD 4.805 billion, a year-on-year increase of 37.33% [1] - China Resources Beer (00291) reported a mid-term profit attributable to shareholders of HKD 5.789 billion, a year-on-year increase of 23.04% [1] - Kunlun Energy (00135) reported a mid-term profit attributable to shareholders of HKD 3.161 billion, a year-on-year decrease of 4.36%, with a dividend of HKD 0.166 per share [1] - WuXi Biologics (02269) reported a mid-term profit attributable to shareholders of approximately HKD 2.339 billion, a year-on-year increase of 56% [1] - Sunny Optical Technology (02382) reported a mid-term profit attributable to shareholders of HKD 1.646 billion, a year-on-year increase of 52.56% [1] - Yixin Group (02858) reported an adjusted net profit of HKD 648 million, a year-on-year increase of 28% [1] - Kangchen Pharmaceutical (01681) reported a mid-term profit attributable to shareholders of HKD 498 million, a year-on-year increase of 24.6%, maintaining market leadership with its flagship product [1] - Ping An Good Doctor (01833) reported a mid-term profit attributable to shareholders of HKD 134 million, a year-on-year increase of 136.84% [1] - China Communication Services (02342) reported a mid-term profit attributable to shareholders of HKD 61.781 million, returning to profitability [1] - XPeng Motors-W (09868) reported record levels in core business and financial metrics for Q2, with a net loss attributable to ordinary shareholders of HKD 480 million, narrowing by 62.8% year-on-year [1] - Guochuang Tongqiao (02190) reported a mid-term profit attributable to shareholders of HKD 121 million, a year-on-year increase of 76% [1] - Yanda Pharmaceutical (00512) reported record revenue of HKD 6.107 billion [1] - Jinli Permanent Magnet (06680) reported a mid-term net profit of approximately HKD 305 million, a year-on-year increase of 154.81% [1] - Zhaogang Group-W (06676) issued a profit warning, expecting a mid-term profit attributable to shareholders of approximately HKD 140 million to HKD 180 million, returning to profitability [1] - Longyuan Power (00916) reported a mid-term profit attributable to equity holders of HKD 3.519 billion, a year-on-year decrease of 14.4% [1] - Yancoal Australia (03668) reported a mid-term profit attributable to shareholders of AUD 16.3 million, a year-on-year decrease of 61.19% [1] - SF Holding (06936) reported combined revenue of HKD 24.847 billion from express logistics, supply chain, and international business in July, a year-on-year increase of 9.95% [1] - Chow Sang Sang (00116) expects a mid-term profit attributable to shareholders from continuing operations of approximately HKD 900 million to HKD 920 million [1]

Core Viewpoint - Xiaomi Group reported a strong revenue growth of 30.5% year-on-year for Q2, driven by IoT and lifestyle products, despite a slight decline in smartphone revenue [2] Financial Performance - Q2 revenue reached 116 billion RMB, with a net profit of 10.8 billion RMB, marking a 75.4% increase year-on-year [2] - Smartphone revenue was 45.5 billion RMB, down 2.1% year-on-year, attributed to a decrease in average selling price (ASP) in overseas markets [2] - IoT and lifestyle products generated 38.7 billion RMB, showing a significant growth of 44.7% year-on-year [2] - Internet services revenue was 9.1 billion RMB, up 10.1% year-on-year [2] - Revenue from innovative segments, including electric vehicles and AI, totaled 21.3 billion RMB, with a loss of 300 million RMB [2] Margin Analysis - The gross margin for smartphones decreased from 12.1% in the previous year to 11.5% in Q2, influenced by increased promotional activities and competition [2][3] - The company anticipates a recovery in smartphone gross margin in Q4, focusing on high-end products and investments in chips, operating systems, and AI [3] Market Outlook - The overall smartphone market growth is expected to be flat or minimal, leading Xiaomi to revise its sales target to approximately 175 million units for the year [3] - The company emphasizes optimizing product structure and improving ASP in response to market conditions [3] R&D Investment - R&D expenditure for Q2 was 7.8 billion RMB, a 41.2% increase year-on-year, with an expected total investment of 30 billion RMB for the year [4] - Cash and cash equivalents decreased from 39.336 billion RMB to 36 billion RMB year-on-year [4]

Core Viewpoint - Xiaomi Group reported a record high revenue of 116 billion RMB for Q2 2025, marking a 30.5% year-on-year increase, and an adjusted net profit of 10.8 billion RMB, up 75.4% year-on-year, indicating strong financial performance and growth potential in key business segments [1][2]. Financial Performance - Revenue for Q2 2025 reached 115,956.1 million RMB, a 30.5% increase from 88,887.8 million RMB in Q2 2024, and a 4.2% increase from 111,293.3 million RMB in Q1 2025 [2]. - Gross profit was 26,101.0 million RMB, up 41.9% year-on-year, and operating profit increased by 128.2% to 13,436.7 million RMB [2]. - Adjusted net profit for the quarter was 10,830.7 million RMB, reflecting a 75.4% increase compared to 6,175.4 million RMB in the same period last year [2]. Business Segments - The smartphone segment generated 455 million RMB in revenue with a shipment of 42.4 million units, showing a slight increase from 42.2 million units year-on-year [3]. - IoT and lifestyle products revenue reached 387 million RMB, a 44.7% increase, with smart home appliances seeing a significant growth of 66.2% [3]. - The automotive and innovative business segment reported revenue of 213 million RMB, a remarkable 234% increase, with 81,302 units delivered in the quarter [3]. Strategic Focus - Xiaomi is focusing on a dual strategy of scaling and high-end positioning in the smartphone market, shifting its focus from the 4000-6000 RMB range to the ultra-high-end segment above 6000 RMB [3][4]. - The company aims to expand its retail presence, targeting 30,000 stores in China and 400-500 overseas by the end of the year [4]. - Xiaomi's goal is to join the "2 billion club" alongside Apple and Samsung within the next three to five years, emphasizing its commitment to growth despite a stagnant global market [4][5]. R&D and Innovation - R&D investment reached a record high of 7.8 billion RMB in Q2 2025, a 41.2% increase, with an annual target of 30 billion RMB [6]. - Key technological advancements are focused on automotive, chips, and AI, including the development of a prototype car and a self-developed 3nm flagship chip [6]. - The company believes that having self-developed chips will create a significant competitive advantage in the future [6].